Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment
- 23 October 2019
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 179 (2) , 287-300
Abstract
With the advent of next generation sequencing technologies, there is an increasingly complex understanding of the role of gastrointestinal and local breast microbial dysbiosis in breast cancer. In this review, we summarize the current understanding of the microbiome’s role in breast carcinogenesis, discussing modifiable risk factors that may affect breast cancer risk by inducing dysbiosis as well as recent sequencing data illustrating breast cancer subtype-specific differences in local breast tissue microbiota. We outline how the ‘estrobolome,’ the aggregate of estrogen-metabolizing enteric bacterial genes, may affect the risk of developing postmenopausal estrogen receptor–positive breast cancer. We also discuss the microbiome’s potent capacity for anticancer therapy activation and deactivation, an important attribute of the gastrointestinal microbiome that has yet to be harnessed clinically.Keywords
This publication has 154 references indexed in Scilit:
- Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer RiskJAMA, 2011
- Microbiome and MalignancyCell Host & Microbe, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseHepatology, 2010
- Phytoestrogen consumption and association with breast, prostate and colorectal cancer in EPIC NorfolkArchives of Biochemistry and Biophysics, 2010
- Targeting the PI3K signaling pathway in cancerCurrent Opinion in Genetics & Development, 2010
- Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolismGenes & Nutrition, 2009
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Human gut microbes associated with obesityNature, 2006